1 September 2020 - 31 August 2021
Parent institution: AstraZeneca UK Limited
Subject/journal group: All
The table to the right includes counts of all research outputs for AstraZeneca Cambridge published between 1 September 2020 - 31 August 2021 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
Outputs by subject (Share)
|Nature Chemical Biology||1||0.29|
|Nature Structural & Molecular Biology||1||0.11|
|Proceedings of the National Academy of Sciences of the United States of America||1||0.04|
|Science Translational Medicine||1||0.06|
|The EMBO Journal||1||0.20|
Top articles by Altmetric score in current window
Landscapes of cellular phenotypic diversity in breast cancer xenografts and their impact on drug response
Depleting plasmacytoid dendritic cells reduces local type I interferon responses and disease activity in patients with cutaneous lupus
Science Translational Medicine
Bicyclic β‐sheet mimetics that target the transcriptional coactivator β‑catenin and inhibit Wnt signaling
Angewandte Chemie International Edition
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.